TrialGynecologic oncology2024

Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine.

Christina A Metcalf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.